Healthcare Stocks

Singapore Exchange (SGX) lists 23 GICS designated healthcare stocks with a combined market capitalisation of S$25.7 billion and generated an average 2014 year-to-date (YTD) total return of 9.6%. According to the Global Industry Classification Standard (GICS), the healthcare industry comprises health care equipment & services and pharmaceuticals and biotechnology & life sciences companies. This is the same benchmark used to classified stocks on SGX StockFacts.

Out of the current 23 stocks, eight are listed on Catalist with the latest addition of QT Vascular in April 2014 and TalkMed Group in January 2014. In addition, SGX-listed stocks IHH Healthcare Berhad and Raffles Medical Group are in the top five largest capitalised stocks of the GICS healthcare sector in the ASEAN region.
Among the 23 stocks, the five largest capitalised healthcare stocks are IHH Healthcare Berhad, Raffles Medical Group, Tianjin Zhongxin Pharmaceutical Group Corporation, Haw Par Corporation and Biosensors International Group. They have a combined market capitalisation of S$22.3 billion and generated average 2014 YTD total return of 6.2%.

In the year thus far, the five best performing healthcare stocks were Health Management International, Singapore Medical Group, Q&M Dental Group Singapore, Religare Health Trust and TalkMed Group. They have a combined market capitalisation of S$1.9 billion and generated median 2014 YTD total return of 40.6%. (Click here to view more)